Henry Schein completes majority stake acquisition in PE-backed BioHorizons

Henry Schein said Tuesday that it has completed its purchase of a 60 percent stake in BioHorizons. No financial terms were disclosed. Based in Birmingham, Alabama, BioHorizons, which is backed by Healthpoint Capital, is a provider of dental implant technology and tissue regeneration products.

DealsNorth AmericaUSBriefs